And a Strop Haria Species and the Detection of Psilocybin
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Diversity of Species of the Genus Conocybe (Bolbitiaceae, Agaricales) Collected on Dung from Punjab, India
Mycosphere 6(1): 19–42(2015) ISSN 2077 7019 www.mycosphere.org Article Mycosphere Copyright © 2015 Online Edition Doi 10.5943/mycosphere/6/1/4 Diversity of species of the genus Conocybe (Bolbitiaceae, Agaricales) collected on dung from Punjab, India Amandeep K1*, Atri NS2 and Munruchi K2 1Desh Bhagat College of Education, Bardwal-Dhuri-148024, Punjab, India 2Department of Botany, Punjabi University, Patiala-147002, Punjab, India. Amandeep K, Atri NS, Munruchi K 2015 – Diversity of species of the genus Conocybe (Bolbitiaceae, Agaricales) collected on dung from Punjab, India. Mycosphere 6(1), 19–42, Doi 10.5943/mycosphere/6/1/4 Abstract A study of diversity of coprophilous species of Conocybe was carried out in Punjab state of India during the years 2007 to 2011. This research paper represents 22 collections belonging to 16 Conocybe species growing on five diverse dung types. The species include Conocybe albipes, C. apala, C. brachypodii, C. crispa, C. fuscimarginata, C. lenticulospora, C. leucopus, C. magnicapitata, C. microrrhiza var. coprophila var. nov., C. moseri, C. rickenii, C. subpubescens, C. subxerophytica var. subxerophytica, C. subxerophytica var. brunnea, C. uralensis and C. velutipes. For all these taxa, dung types on which they were found growing are mentioned and their distinctive characters are described and compared with similar taxa along with a key for their identification. The taxonomy of ten taxa is discussed along with the drawings of morphological and anatomical features. Conocybe microrrhiza var. coprophila is proposed as a new variety. As many as six taxa, namely C. albipes, C. fuscimarginata, C. lenticulospora, C. leucopus, C. moseri and C. -
Fungal Planet Description Sheets: 716–784 By: P.W
Fungal Planet description sheets: 716–784 By: P.W. Crous, M.J. Wingfield, T.I. Burgess, G.E.St.J. Hardy, J. Gené, J. Guarro, I.G. Baseia, D. García, L.F.P. Gusmão, C.M. Souza-Motta, R. Thangavel, S. Adamčík, A. Barili, C.W. Barnes, J.D.P. Bezerra, J.J. Bordallo, J.F. Cano-Lira, R.J.V. de Oliveira, E. Ercole, V. Hubka, I. Iturrieta-González, A. Kubátová, M.P. Martín, P.-A. Moreau, A. Morte, M.E. Ordoñez, A. Rodríguez, A.M. Stchigel, A. Vizzini, J. Abdollahzadeh, V.P. Abreu, K. Adamčíková, G.M.R. Albuquerque, A.V. Alexandrova, E. Álvarez Duarte, C. Armstrong-Cho, S. Banniza, R.N. Barbosa, J.-M. Bellanger, J.L. Bezerra, T.S. Cabral, M. Caboň, E. Caicedo, T. Cantillo, A.J. Carnegie, L.T. Carmo, R.F. Castañeda-Ruiz, C.R. Clement, A. Čmoková, L.B. Conceição, R.H.S.F. Cruz, U. Damm, B.D.B. da Silva, G.A. da Silva, R.M.F. da Silva, A.L.C.M. de A. Santiago, L.F. de Oliveira, C.A.F. de Souza, F. Déniel, B. Dima, G. Dong, J. Edwards, C.R. Félix, J. Fournier, T.B. Gibertoni, K. Hosaka, T. Iturriaga, M. Jadan, J.-L. Jany, Ž. Jurjević, M. Kolařík, I. Kušan, M.F. Landell, T.R. Leite Cordeiro, D.X. Lima, M. Loizides, S. Luo, A.R. Machado, H. Madrid, O.M.C. Magalhães, P. Marinho, N. Matočec, A. Mešić, A.N. Miller, O.V. Morozova, R.P. Neves, K. Nonaka, A. Nováková, N.H. -
Review of Psilocybin/Psilocin Pharmacology Isaac Dehart
Review of Psilocybin/Psilocin Pharmacology Isaac DeHart Introduction Psilocybin (PY, 4-phosphoryloxy-N,N-dimethyltryptamine or O-phosphoryl-4-hydroxy- N,N-dimethyltryptamine) (Figure 1, 1) is an indolamine (Figure 1, 2), and the primary ingredient in magic mushrooms. It has been implicated as a treatment for a number of psychological ailments including depression, general anxiety disorder, various addictions, obsessive- compulsive disorder, and post-traumatic stress disorder.1–4 Because of the drug’s re-emerging relevance in clinical applications, and because of its distinctive and informative effects on brain function, it is important to understand the pharmacology and general chemistry underlying its metabolism. Psilocybin is a prodrug of psilocin Magic mushrooms, the natural source of psilocybin may refer to several different hallucination-causing fungi, but the most potent of these are found in the genus Psilocybe. When ingested, magic mushrooms cause “trips,” wherein a user experiences euphoria, colorful hallucinations, and changes in perception, cognition and mood. In the case of “bad trips,” a user may experience states of intense panic or paranoia.5,6 More generally, these trips are sometimes described in terms of psychotic states, and behavioral studies involving psilocybin have demonstrated similarities between the effects of psilocybin and schizophrenia both in subjective experience and in physiological response.7 While psilocybin is more widely known as the cause behind these effects, it is referred to by researchers as a prodrug, -
Specificity of the Antibody Receptor Site to D-Lysergamide
Proc. Nat. Acad. Sci. USA Vol. 68, No. 7, pp. 1483-1487, July 1971 Specificity of the Antibody Receptor Site to D-Lysergamide: Model of a Physiological Receptor for Lysergic Acid Diethylamide (molecular structure/hallucinogenic/rabbit/guinea pig/psychotomimetic) HELEN VAN VUNAKIS, JOHN T. FARROW, HILDA B. GJIKA, AND LAWRENCE LEVINE Graduate Department of Biochemistry, Brandeis University, Waltham, Massachusetts 02154 Commnunicated by Francis 0. Schmitt, April 21, 1971 ABSTRACT Antibodies to D-lysergic acid have been amine, and NN-dimethyl-3,4,5-trimethoxyphenylethylamine produced in rabbits and guinea pigs and a radioimmuno- were the generous gifts of Dr. W. E. Scott of Hoffmann-La assay for the hapten was developed. The specificity of this Iysergamide-antilysergamide reaction was determined by Roche. DOM (2,5-dimethoxy-4-methylamphetamine) was competitive binding with unlabeled lysergic acid diethyl- given to us by Dr. S. H. Snyder of Johns Hopkins Univer- amnide (LSD), psychotomimetic drugs, neurotransmitters, sity. Sandoz Pharmaceuticals provided us with ergonovine, and other compounds with diverse structures. LSD and methylergonovine, ergosine, and ergotomine. LSD tartarate several related ergot alkaloids were potent competitors, three to seven times more potent than lysergic acid itself. powder (Sandoz Batch no. 98601) and psilocybin powder The NN-dimethyl derivatives of several compounds, in- (Sandoz Batch no. 55001) were provided by the U.S. Food and cluding tryptamine, 5-hydroxytryptamine, 4-hydroxy- Drug Administration and the National Institute of Mental tryptamine, 5-methoxytryptamine, tyramine, and mesca- Health. line, were only about ten times less effective than lysergic Psilocin was obtained by dephosphorylating psilocybin acid, even though these compounds lack some of the ring systems of lysergic acid. -
Bibliotheksliste-Aarau-Dezember 2016
Bibliotheksverzeichnis VSVP + Nur im Leesesaal verfügbar, * Dissert. Signatur Autor Titel Jahrgang AKB Myc 1 Ricken Vademecum für Pilzfreunde. 2. Auflage 1920 2 Gramberg Pilze der Heimat 2 Bände 1921 3 Michael Führer für Pilzfreunde, Ausgabe B, 3 Bände 1917 3 b Michael / Schulz Führer für Pilzfreunde. 3 Bände 1927 3 Michael Führer für Pilzfreunde. 3 Bände 1918-1919 4 Dumée Nouvel atlas de poche des champignons. 2 Bände 1921 5 Maublanc Les champignons comestibles et vénéneux. 2 Bände 1926-1927 6 Negri Atlante dei principali funghi comestibili e velenosi 1908 7 Jacottet Les champignons dans la nature 1925 8 Hahn Der Pilzsammler 1903 9 Rolland Atlas des champignons de France, Suisse et Belgique 1910 10 Crawshay The spore ornamentation of the Russulas 1930 11 Cooke Handbook of British fungi. Vol. 1,2. 1871 12/ 1,1 Winter Die Pilze Deutschlands, Oesterreichs und der Schweiz.1. 1884 12/ 1,5 Fischer, E. Die Pilze Deutschlands, Oesterreichs und der Schweiz. Abt. 5 1897 13 Migula Kryptogamenflora von Deutschland, Oesterreich und der Schweiz 1913 14 Secretan Mycographie suisse. 3 vol. 1833 15 Bourdot / Galzin Hymenomycètes de France (doppelt) 1927 16 Bigeard / Guillemin Flore des champignons supérieurs de France. 2 Bände. 1913 17 Wuensche Die Pilze. Anleitung zur Kenntnis derselben 1877 18 Lenz Die nützlichen und schädlichen Schwämme 1840 19 Constantin / Dufour Nouvelle flore des champignons de France 1921 20 Ricken Die Blätterpilze Deutschlands und der angr. Länder. 2 Bände 1915 21 Constantin / Dufour Petite flore des champignons comestibles et vénéneux 1895 22 Quélet Les champignons du Jura et des Vosges. P.1-3+Suppl. -
Baeocystin in Psilocybe, Conocybe and Panaeolus
Baeocystin in Psilocybe, Conocybe and Panaeolus DAVIDB. REPKE* P.O. Box 899, Los Altos, California 94022 and DALE THOMASLESLIE 104 Whitney Avenue, Los Gatos, California 95030 and GAST6N GUZMAN Escuela Nacional de Ciencias Biologicas, l.P.N. Apartado Postal 26-378, Mexico 4. D.F. ABSTRACT.--Sixty collections of ten species referred to three families of the Agaricales have been analyzed for the presence of baeocystin by thin-layer chro- matography. Baeocystin was detected in collections of Peilocy be, Conocy be, and Panaeolus from the U.S.A., Canada, Mexico, and Peru. Laboratory cultivated fruit- bodies of Psilocybe cubensis, P. sernilanceata, and P. cyanescens were also studied. Intra-species variation in the presence and decay rate of baeocystin, psilocybin, and psilocin are discussed in terms of age and storage factors. In addition, evidence is presented to support the presence of 4-hydroxytryptamine in collections of P. baeo- cystis and P. cyanescens. The possible significance of baeocystin and 4·hydroxy- tryptamine in the biosynthesis of psilocybin in these organisms is discussed. A recent report (1) described the isolation of baeocystin [4-phosphoryloxy-3- (2-methylaminoethyl)indole] from collections of Psilocy be semilanceata (Fr.) Kummer. Previously, baeocystin had been detected only in Psilocybe baeo- cystis Singer and Smith (2, 3). This report now describes some further obser- vations regarding the occurrence of baeocystin in species referred to three families of Agaricales. Stein, Closs, and Gabel (4) isolated a compound from an agaric that they described as Panaeolus venenosus Murr., a species which is now considered synonomous with Panaeolus subbaIteatus (Berk. and Br.) Sacco (5, 6). -
Toxic Fungi of Western North America
Toxic Fungi of Western North America by Thomas J. Duffy, MD Published by MykoWeb (www.mykoweb.com) March, 2008 (Web) August, 2008 (PDF) 2 Toxic Fungi of Western North America Copyright © 2008 by Thomas J. Duffy & Michael G. Wood Toxic Fungi of Western North America 3 Contents Introductory Material ........................................................................................... 7 Dedication ............................................................................................................... 7 Preface .................................................................................................................... 7 Acknowledgements ................................................................................................. 7 An Introduction to Mushrooms & Mushroom Poisoning .............................. 9 Introduction and collection of specimens .............................................................. 9 General overview of mushroom poisonings ......................................................... 10 Ecology and general anatomy of fungi ................................................................ 11 Description and habitat of Amanita phalloides and Amanita ocreata .............. 14 History of Amanita ocreata and Amanita phalloides in the West ..................... 18 The classical history of Amanita phalloides and related species ....................... 20 Mushroom poisoning case registry ...................................................................... 21 “Look-Alike” mushrooms ..................................................................................... -
Test Purchase of New Synthetic Tryptamines Via the Internet: Identity Check by GC-MS and Separation by HPLC
Journal of Applied Pharmaceutical Science Vol. 6 (01), pp. 028-034, January, 2016 Available online at http://www.japsonline.com DOI: 10.7324/JAPS.2016.600105 ISSN 2231-3354 Test purchase of new synthetic tryptamines via the Internet: Identity check by GC-MS and separation by HPLC Magdalena Taschwer, Edith Ebner, Martin G Schmid* Department of Pharmaceutical Chemistry, Institute of Pharmaceutical Sciences, University of Graz, Universitätsplatz 1, A-8010 Graz, Austria. ABSTRACT ARTICLE INFO Article history: Over the past few years, a continuous alteration of the recreational drug market took place. Among other novel Received on: 25/09/2015 psychoactive drugs, new synthetic tryptamine derivatives appeared on the market. These compounds are mainly Revised on: 18/10/2015 traded via the Internet, which has become an important marketplace for the sale of recreational drugs. The goal of Accepted on: 08/11/2015 our research was to check, if 13 new synthetic tryptamines obtained by test purchase via different online vendors Available online: 26/01/2016 meet the promised identity. Analysis was performed by GC-MS, using a common 30 m HP-5MS capillary column as stationary phase. Subsequently, a simple HPLC method for the separation of these tryptamines was Key words: developed. Therefore, the aim was to establish a method to separate a broad spectrum of trypamines Tryptamines, Legal highs, simultaneously within short time. Measurements were performed by a LiChrospher® RP-18e column and a Novel psychoactive drugs, mobile phase consisting of 0.1% triethylammonium acetate buffer, methanol and acetonitrile. Both presented HPLC, GC-MS. methods were found to be suitable for the identification as well as separation of tryptamines as the analysis times were short and the selectivity sufficient. -
Conocybe Aeruginosa
© Demetrio Merino Alcántara [email protected] Condiciones de uso Conocybe aeruginosa Romagn., Bull. trimest. Soc. mycol. Fr. 84: 368 (1969) [1968] 10 mm Bolbitiaceae, Agaricales, Agaricomycetidae, Agaricomycetes, Agaricomycotina, Basidiomycota, Fungi Sinónimos homotípicos: Pholiotina aeruginosa (Romagn.) M.M. Moser, in Gams, Kl. Krypt.-Fl., Bd II b/2, ed. 4 (Stuttgart) 2b/2: 283 (1978) Material estudiado: Francia, Aquitania, Pirineos Atlánticos, Osse en Aspe, L'Aidy, 30TXN8763, 675 m, en hojas caídas de Fagus sylvatica, 6-X-2012, leg. Dianora Estrada y Demetrio Merino, JA-CUSSTA: 9410. Descripción macroscópica: Píleo de 14-21 mm de diám., campanulado a plano convexo, con umbón obtuso, margen ondulado, agudo. Cutícula estriada ra- dialmente, mate, de color azul verdoso con el centro más oscuro. Láminas adnadas, separadas, de color marrón rojizo, arista flocu- losa, más clara. Estípite de 28-37 x 2-3 mm, cilíndrico, rígido, frágil, liso, de color blanquecino, blanquecino ocráceo hacia la base, con el ápice estriado. Olor inapreciable. Descripción microscópica: Basidios claviformes, tetraspóricos, con fíbula basal, de (18,2-)19,5-25,7(-26,8) × (6,3-)7,6-9,5(-9,8) µm; N = 31; Me = 22,4 × 8,4 µm. Basidiosporas elipsoidales a subcilíndricas, amigdaliformes, con poro apical central e indistinto, lisas, hialinas, apiculadas, gutuladas, de (7,6-)8,4-9,9(-10,6) × (4,1-)4,7-5,5(-5,9) µm; Q = (1,5-)1,6-1,9(-2,1); N = 105; V = (72-)100-151(-181) µm3; Me = 9,1 × 5,1 µm; Qe = 1,8; Ve = 126 µm3. Queilocistidios fusiformes a lageniformes, con largo cuello, de (20,0-)23,0-42,4(-45,0) × (4,5-)4,8- 9,5(-12,7) µm; N = 13; Me = 34,4 × 7,1 µm. -
Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans
molecules Review Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans Paul Cumming 1,2,* , Milan Scheidegger 3 , Dario Dornbierer 3, Mikael Palner 4,5,6 , Boris B. Quednow 3,7 and Chantal Martin-Soelch 8 1 Department of Nuclear Medicine, Bern University Hospital, CH-3010 Bern, Switzerland 2 School of Psychology and Counselling, Queensland University of Technology, Brisbane 4059, Australia 3 Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital of the University of Zurich, CH-8032 Zurich, Switzerland; [email protected] (M.S.); [email protected] (D.D.); [email protected] (B.B.Q.) 4 Odense Department of Clinical Research, University of Southern Denmark, DK-5000 Odense, Denmark; [email protected] 5 Department of Nuclear Medicine, Odense University Hospital, DK-5000 Odense, Denmark 6 Neurobiology Research Unit, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark 7 Neuroscience Center Zurich, University of Zurich and Swiss Federal Institute of Technology Zurich, CH-8058 Zurich, Switzerland 8 Department of Psychology, University of Fribourg, CH-1700 Fribourg, Switzerland; [email protected] * Correspondence: [email protected] or [email protected] Abstract: Hallucinogens are a loosely defined group of compounds including LSD, N,N- dimethyltryptamines, mescaline, psilocybin/psilocin, and 2,5-dimethoxy-4-methamphetamine (DOM), Citation: Cumming, P.; Scheidegger, which can evoke intense visual and emotional experiences. We are witnessing a renaissance of re- M.; Dornbierer, D.; Palner, M.; search interest in hallucinogens, driven by increasing awareness of their psychotherapeutic potential. Quednow, B.B.; Martin-Soelch, C. As such, we now present a narrative review of the literature on hallucinogen binding in vitro and Molecular and Functional Imaging ex vivo, and the various molecular imaging studies with positron emission tomography (PET) or Studies of Psychedelic Drug Action in single photon emission computer tomography (SPECT). -
Collecting and Recording Fungi
British Mycological Society Recording Network Guidance Notes COLLECTING AND RECORDING FUNGI A revision of the Guide to Recording Fungi previously issued (1994) in the BMS Guides for the Amateur Mycologist series. Edited by Richard Iliffe June 2004 (updated August 2006) © British Mycological Society 2006 Table of contents Foreword 2 Introduction 3 Recording 4 Collecting fungi 4 Access to foray sites and the country code 5 Spore prints 6 Field books 7 Index cards 7 Computers 8 Foray Record Sheets 9 Literature for the identification of fungi 9 Help with identification 9 Drying specimens for a herbarium 10 Taxonomy and nomenclature 12 Recent changes in plant taxonomy 12 Recent changes in fungal taxonomy 13 Orders of fungi 14 Nomenclature 15 Synonymy 16 Morph 16 The spore stages of rust fungi 17 A brief history of fungus recording 19 The BMS Fungal Records Database (BMSFRD) 20 Field definitions 20 Entering records in BMSFRD format 22 Locality 22 Associated organism, substrate and ecosystem 22 Ecosystem descriptors 23 Recommended terms for the substrate field 23 Fungi on dung 24 Examples of database field entries 24 Doubtful identifications 25 MycoRec 25 Recording using other programs 25 Manuscript or typescript records 26 Sending records electronically 26 Saving and back-up 27 Viruses 28 Making data available - Intellectual property rights 28 APPENDICES 1 Other relevant publications 30 2 BMS foray record sheet 31 3 NCC ecosystem codes 32 4 Table of orders of fungi 34 5 Herbaria in UK and Europe 35 6 Help with identification 36 7 Useful contacts 39 8 List of Fungus Recording Groups 40 9 BMS Keys – list of contents 42 10 The BMS website 43 11 Copyright licence form 45 12 Guidelines for field mycologists: the practical interpretation of Section 21 of the Drugs Act 2005 46 1 Foreword In June 2000 the British Mycological Society Recording Network (BMSRN), as it is now known, held its Annual Group Leaders’ Meeting at Littledean, Gloucestershire. -
Infrageneric Division of the Genus Conocybe - a Classical Approach
ZOBODAT - www.zobodat.at Zoologisch-Botanische Datenbank/Zoological-Botanical Database Digitale Literatur/Digital Literature Zeitschrift/Journal: Österreichische Zeitschrift für Pilzkunde Jahr/Year: 2006 Band/Volume: 15 Autor(en)/Author(s): Hausknecht Anton, Krisai-Greilhuber Irmgard Artikel/Article: Infrageneric division of the genus Conocybe - a classical approach. 187-212 ©Österreichische Mykologische Gesellschaft, Austria, download unter www.biologiezentrum.at Österr. Z. Pilzk. 15 (2006) 187 Infrageneric division of the genus Conocybe - a classical approach ANTON HAUSKNECHT Sonndorferstraße 22 A-3712 Maissau, Austria Email: [email protected] IRMGARD KRISAI-GREILHUBER Institut für Botanik der Universität Wien Rennweg 14 A-1030 Wien, Austria Email: [email protected] Accepted 18. 9. 2006 Key words: Agaricales, Bolbitiaceae, Conocybe, Gastrocybe. - Infrageneric classification of the ge- nus Conocvbe. - New taxa, new combinations. Abstract: An infrageneric concept of the genus Conocybe including all hitherto known taxa world- wide is presented. New sections, subsections and series are proposed along with listing all representa- tives in the respective categories. Gastrocybe is included in Conocybe sect. Candidae. Zusammenfassung: Ein infragenerisches Konzept der Gattung Conocvbe auf Basis aller bisher welt- weit bekannten Taxa wird vorgestellt. Neue Sektionen, Subsektionen und Serien werden vorgeschla- gen und die jeweiligen Vertreter diesen zugeordnet. Die Gattung Gastrocybe wird in Conocybe sect. Candidae eingeordnet. While preparing a monographical study of the European taxa of the genus Conocybe, the first author has studied nearly all type specimens worldwide. Only very few type specimens, marked by (*) in the list, could not be examined microscopically so far. Subsequently, it is attempted to bring all resulting insights into a worldwide infra- generic concept of the genus.